Invention Grant
- Patent Title: Recombinant RSV virus expression systems and vaccines
- Patent Title (中): 重组RSV病毒表达系统和疫苗
-
Application No.: US11078900Application Date: 2005-03-11
-
Publication No.: US07465574B2Publication Date: 2008-12-16
- Inventor: Hong Jin , Roderick Tang , Shengqiang Li , Martin Bryant
- Applicant: Hong Jin , Roderick Tang , Shengqiang Li , Martin Bryant
- Applicant Address: US MD Gaithersburg
- Assignee: MedImmune, LLC
- Current Assignee: MedImmune, LLC
- Current Assignee Address: US MD Gaithersburg
- Main IPC: C12N7/00
- IPC: C12N7/00 ; C12N7/02 ; C12N7/04 ; C07H21/00
Abstract:
The present invention relates to genetically engineered recombinant RS viruses and viral vectors which contain heterologous genes which for the use as vaccines. In accordance with the present invention, the recombinant RS viral vectors and viruses are engineered to contain heterologous genes, including genes of other viruses, pathogens, cellular genes, tumor antigens, or to encode combinations of genes from different strains of RSV.
Public/Granted literature
- US20050164175A1 Recombinant RSV virus expression systems and vaccines Public/Granted day:2005-07-28
Information query
